advertisement
Onoe H 9
Showing records 1 to 9 | Display all abstracts from Onoe H96144 The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
Onoe H
Journal of clinical medicine 2021; 10:
96530 Corneal Higher-Order Aberrations after Microhook ab Interno Trabeculotomy and Goniotomy with the Kahook Dual Blade: Preliminary Early 3-Month Results
Onoe H
Journal of clinical medicine 2021; 10:
96144 The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
Hirooka K
Journal of clinical medicine 2021; 10:
96530 Corneal Higher-Order Aberrations after Microhook ab Interno Trabeculotomy and Goniotomy with the Kahook Dual Blade: Preliminary Early 3-Month Results
Hirooka K; Okumichi H
Journal of clinical medicine 2021; 10:
96144 The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
Nagayama M; Hirota A
Journal of clinical medicine 2021; 10:
96530 Corneal Higher-Order Aberrations after Microhook ab Interno Trabeculotomy and Goniotomy with the Kahook Dual Blade: Preliminary Early 3-Month Results
Murakami Y
Journal of clinical medicine 2021; 10:
96144 The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
Mochizuki H
Journal of clinical medicine 2021; 10:
96530 Corneal Higher-Order Aberrations after Microhook ab Interno Trabeculotomy and Goniotomy with the Kahook Dual Blade: Preliminary Early 3-Month Results
Kiuchi Y
Journal of clinical medicine 2021; 10:
96144 The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
Sagara T; Suzuki K; Okumichi H; Kiuchi Y
Journal of clinical medicine 2021; 10:
